ライフサイエンスコーパス: be as follows

1 The mechanism for this is as follows.

2 Notable features are as follows.

3 Details are as follows.

4 Our key findings are as follows.

5 Our main findings are as follows.

6 l properties obtained following optimization were as follows.

7 appa coefficient of agreement (kappa = 0.69) was as follows: 0 (no itch), 1-3 (mild itch), 4-7 (moder

8 he individual probability of gestational VTE was as follows: 0.7% (0.5%) for heterozygous FVL; 3.4% (

9 ian complication rates per 1000 patient days were as follows: 0.04 aneurysms (14 unique cohorts; n=18

10 detection of the method for the antioxidants were as follows: 0.5-3 mg L(-1) and 0.27 mg L(-1) for GA

11 The estimated parameters were as follows: 0.80 for the absorption rate [h(-1)], 5

12 Bundle elements are as follows: 1) blood cultures before antibiotics; 2)

13 The next steps of the group's work are as follows: 1) establishing a consortium of oral hea

14 The aims of this study are as follows: 1) to evaluate the possibility of a corr

15 The isocaloric diets were as follows: 1) a high-cheese (96-120-g) interventio

16 wo identified key strategies to achieve this were as follows: 1) a new authority for robust cross-gov

17 Inclusion criteria were as follows: 1) adult patients (n = 274) diagnosed w

18 Study groups were as follows: 1) empty defect (control, n = 14); 2) x

19 Study groups were as follows: 1) non-ligated control (NL, n = 6); 2)

20 Participant classifications were as follows: 1) optimal-normal blood pressure (BP) (

21 number of emergency department sepsis visits were as follows: 1) original emergency department sepsis

22 derstanding of the essentiality of n-3 PUFAs were as follows: 1) their role is in neural function, wh

23 The main observations were as follows: 1) there were shorter leukocyte telomer

24 erived tissue, the aims of the current study were as follows: 1) to examine the expression and conten

25 000 IU cholecalciferol groups, respectively, were as follows: 1) total 25-hydroxyvitamin D, 3% (-3% t

26 The extracorporeal life support cohorts were as follows: 1) veno-venous extracorporeal membrane

27 The correct affiliations are as follows: "(1)Institute of Immunology and Immunoth

28 The main contributions of this study are as follows: (1) an end-to-end model based on CapsNet

29 Two major findings are as follows: (1) Ku specifically binds to telomerase

30 edication costs to patients, recommendations are as follows: (1) selection of insurance plans whose f

31 Our major findings are as follows: (1) the result of Fst showed largemouth

32 exta, we found chemical-specific information is as follows: (1) initially encoded in the population o

33 Our scheme was as follows: (1) T7 bacteriophage-conjugated magnetic

34 The main steps were as follows: (1) an initial propensity to trust base

35 Inclusion criteria were as follows: (1) AQP4-IgG seropositivity, (2) myelit

36 k with >/=6 months of sustainable employment were as follows: (1) arrest during 2006-2011 versus 2001

37 These groups were as follows: (1) never adherent after their index pr

38 Our major findings were as follows: (1) severe clinical outcome (ICU treatm

39 (with interquartile range) for each scenario were as follows: (1) severe undifferentiated, 90% (89.5%

40 The control conditions were as follows: (1) sham, (2) transcranial random noise

41 Exclusion criteria were as follows: (1) the purpose of the differential dia

42 Therefore, the aims of the present work were as follows: (1) to develop a treadmill allowing the

43 The objectives of the symposia were as follows: (1) to identify and discuss the barrier

44 The goals for the present study were as follows: (1) to identify critical molecular dete

45 rganism targets, sensitivity and specificity were as follows: 100% each for Cryptococcus neoformans a

46 nal diagnoses of 133 nodules in 159 patients were as follows: 102 hepatocellular carcinomas (HCCs), t

47 dilator and postbronchodilator FEV(1) growth were as follows: 107 mL/y (95% CI, 37-177 mL/y; P(int) =

48 Treatment target concentrations are as follows: 120-360 mumol/L for individuals aged 0-1

49 Its racial/ethnic makeup was as follows: 13% Hispanic, 37% White, 37% Black, and

50 st 3 months, the numbers of symptomatic VTEs were as follows: 15 of 152 patients in the observation g

51 ates for the adjusted prevalence differences were as follows: 16.5 (95% CI: 11.1 to 21.9) for decayed

52 flow at 25% to 75% of vital capacity growth were as follows: 182 mL/y (95% CI, 61-304 mL/y; P(int) =

53 highest-ranking class compared with placebo were as follows: 1991: beta-blockers, 4.01 (CrI, 0.48 to

54 Ten-year CSS according to age was as follows: 2 to 19 years, 99.8%; 20 to 29 years, 99

55 Other organ mean absorbed doses were as follows: 2.7 mGy, liver; 2.1 mGy, red marrow; 1.

56 BMI in the highest and lowest social classes were as follows: 24.9 (0.8) versus 26.8 (0.7) in the 194

57 Percents of patients in each category were as follows: 26.9%, 46.3%, and 26.8% for short, medi

58 The nitrofuran metabolites investigated were as follows: 3-amino-2-oxazolidinone (AOZ), 3-amino-

59 Outcomes were as follows: 339 of the 435 patients (78%) did not h

60 5th percentiles (p25-p75)) for AUC at 1 year were as follows: 349 (337-351) for LC and 349 (338-350)

61 The clinical features were as follows: 36.4% had immature retina without ROP,

62 two-year cumulative incidence of lymphedema was as follows: 4.08% [95% confidence interval (CI): 2.5

63 ve for Chronic Obstructive Lung Disease) 0-4 was as follows: 41.8 (47.7), 53.8 (57.1), 45.6 (61.1), 3

64 Positivity among HHCs were as follows: 49% (51 of 104) for nasal swab samples,

65 mutually exclusive substance use categories were as follows: 5% meth injection (5%), meth use withou

66 s at baseline and the maximal tolerated dose were as follows: 51.3 (95% CI 49.0-53.6) at baseline, 40

67 The lenses implanted were as follows: 53 V4 model ICLs of -15.5 D or greater,

68 eristics of the 860 participants at baseline were as follows: 53% female, 49% African; median age, 34

69 Clinical evaluation at follow-up was as follows: 56% of patients were asymptomatic, 24% h

70 ted hazard ratio and 95% CI for death by LSM were as follows: 6-9.4 kPa, 1.7 (0.63-4.79), P = 0.288;

71 d subhazard ratio and 95% CI by LSM category were as follows: 6-9.4 kPa, 1.89 (0.18-20.3), P = 0.599;

72 Reference values (lower limits of normality) were as follows: 6-segment RVLS, -24.7+/-2.6% (-20.0%) f

73 The distributions of Child-Pugh scores were as follows: 66% class A, 31% class B, and 3% class

74 The MFI distribution of DSA+ recipients were as follows: 66% had MFI 1000 to 4999, 14% had MFI 5

75 ayments for each incremental year of patency were as follows: $71 000 for radiologists, $89 000 for n

76 The proportion of different cancers was as follows: 72% patients were included in the colore

77 phic characteristics of the study population were as follows: 80/109 (73%) individuals were Spanish-b

78 cs of swabs with and without visible pigment were as follows: 92.2% (95% confidence interval [CI], 90

79 gression-free survival, and overall survival were as follows: 95%, 91%, 86%, and 95%, respectively.

80 BD Max EBP assay for all specimens combined were as follows: 97.1% and 99.2% for Salmonella spp., 99

81 wing discrepant analysis, PPA and NPA values were as follows: 97.3% and 99.8% for Salmonella spp., 99

82 The key features of our route are as follows: a Diels-Alder reaction of masked o-benzo

83 he detection of perforated appendicitis (5b) was as follows: a sensitivity of 44.0% (80 of 182), a sp

84 The limitations of our study were as follows: a relatively short duration of treatmen

85 ons between bacterial levels and prediabetes were as follows: A. actinomycetemcomitans, 2.48 (1.34, 4

86 The key results are as follows: (a) Inter-model variation is generally l

87 The incidence of LV thrombus was as follows: (a) nonanterior infarction, LVEF 50% or

88 Seroconversion after 2 IPV doses in each arm were as follows: (A) 97.3% (90.6-99.7), 98.7% (92.7-99.9

89 Additional inclusion criteria were as follows: (a) The medical examiner determined tha

90 he sensitivity and specificity of the assays were as follows: Abbott ARCHITECT, 93.4% (95% CI, 90.1%

91 overall (with prevalence rates per families) were as follows: ABCA4 (20.8%), USH2A (9.1%), RPGR (5.1%

92 Results Mean screening performance measures were as follows: abnormal interpretation rate (AIR), 11.

93 The disease activity distribution was as follows: active disease = 40.1% (US) and 33.6% (E

94 The geographic distribution of responders was as follows: Africa-Middle East 3.0%, Asia-Pacific 21

95 Diagnosis by age range was as follows: age 1 to 14 years, 78%; age 15 to 24 yea

96 Exclusion criteria were as follows: age less than 16 years old, patients wi

97 embryo sensitive period (6-12 wk gestation) were as follows: aHR = 1.04 (95% CI 0.54-2.01), I2 = 0%,

98 Event rates for the individual components were as follows: all-cause mortality, 3.2% versus 2.3% (

99 t to 1 mg of oral risperidone, respectively, were as follows: amisulpride for patients with positive

100 at 12 weeks after end of treatment (SVR 12) were as follows: Among 76 patients with genotype 1 infec

101 an ADR, antibiotics most commonly prescribed were as follows: amoxicillin < cephalosporins < erythrom

102 rameters obtained using the developed ANN-GA were as follows: an incubation time of 64 min, incubatio

103 s (mean percentage of MF within the section) were as follows: anterior 11.9%, anterolateral 15.8%, in

104 volumes arising from unapproved formulations were as follows: anti-depressants/benzodiazepines, 69%;

105 For current use, the estimates were as follows: any (HR, 0.63; 95% CI, 0.61-0.65), comb

106 rd blood metal concentrations, respectively, were as follows: arsenic, 1.4 (1.0-2.3) and 2.4 (1.8-3.3

107 ce estimates of elevated liver abnormalities were as follows: aspartate transaminase 15.0% (95% CI, 1

108 s coproduced, the sensitivities of the tests were as follows: ATM plus CA, 100%; CLSI plus BA, 93.3%;

109 The percentages of ESBL producers detected were as follows: ATM plus CA, 95.7%; CLSI plus BA, 88.6%

110 hich produced a maximum SDF value of 30.36%, were as follows: barrel temperature, 129 degrees C; feed

111 dered from the most to least effective drugs were as follows: bimatoprost 5.61 (4.94; 6.29), latanopr

112 ivers with comparable manipulation intensity was as follows: biodiversity>grazing>precipitation>N.

113 The PFAA concentration ranges observed are as follows: biosolid-based products (9.0-199 mug/kg)

114 or identification of resistance determinants was as follows; blaCTX-M, 98.9%; blaKPC, 100%; blaNDM, 9

115 entages and associated complications of LAUP are as follows: bleeding (2.6%), candidiasis (0.3%), dry

116 body-treated versus control tumors at day 14 was as follows: BR1, 5.2 au (interquartile range [IQR],

117 Our main findings are as follows: brain edema mimicking hypoosmotic condit

118 Indications for screening were as follows: BRCA mutation carrier or history of che

119 Nutritional factors assessed at baseline were as follows: breastfeeding status and timing of comp

120 inal/choroidal layer in decreasing frequency were as follows: Bruch membrane/retinal pigment epitheli

121 of episodes of dental pain and/or infection were as follows: C+P, 0.62 (0.95); B+P, 0.58 (0.87); and

122 st 1 episode of dental pain and/or infection were as follows: C+P, 42%; B+P, 40%; PA, 45%.

123 ults Overall diagnostic performance measures were as follows: cancer detection rate, 34.7 per 1000 (9

124 ts and 95% confidence intervals) on outcomes were as follows: carotid intima-media thickness, 0.01 mm

125 Data for the baked cookies were as follows: casein, 84-90%; soy protein, 80-88%, an

126 Resulting CCI scores were as follows: CCI 2, n = 589; CCI 3 or 4, n = 599; CC

127 anisms in primary S. venezuelensis infection is as follows: CD4(+) T cells/ILC2 cells, IgG, and FcRga

128 ty rates, MIC(50) values, and MIC(90) values were as follows: ceftazidime-avibactam, 92.8%, 2 mug/ml,

129 In Hubei, the baseline estimates were as follows: CFR 2.4% (95% credible interval [CrI] 2

130 increase in prevalence in adults with asthma were as follows: chronic obstructive pulmonary disease (

131 The subtypes of RCC were as follows: clear cell carcinomas (n=23), papillary

132 relationships of the five subfamilies should be as follows: Coeliadinae + (Eudaminae + (Pyrginae + (H

133 y (without commas); the correct gene symbols are as follows: column 3 row 13, RBM17, IL2RA; column 3

134 The eligibility criteria were as follows: comparative studies of ROP patients tha

135 On a patient level, metabolic response was as follows: complete response, n = 1; partial respon

136 adults with asthma compared to those without were as follows: COPD (adjusted odds ratio [aOR] 5.65, 9

137 Copy number distribution was as follows: copy number neutral (NAFLD: 53.8%, contr

138 dentify persons at low risk of complications were as follows: CP <5; MELD <8; FIB-4 <3 for HD and HCC

139 e in the categories of never or almost never were as follows: CRP: 0.80 (0.69, 0.90), P-trend = 0.000

140 nsuspicious by using the five input features were as follows: CT alone, 0.78 (95% confidence interval

141 estimated policy effects on mortality rates are as follows: current tax increase, -3.2%; value-based

142 f participants with individual MRI features, was as follows: curvilinear contact length, 88 of 208 (4

143 incidences of infection for each herpesvirus were as follows: cytomegalovirus (CMV), 44%; human herpe

144 of sentinel outcomes per 10,000 person-years were as follows: death from any cause, -31.4 (95% confid

145 on-years among patients with type 2 diabetes were as follows: death from any cause, -69.6 (95% CI, -9

146 esults for components of the primary outcome were as follows: death from cardiovascular causes, 15 of

147 At 6 months, the GOS-E distributions were as follows: death, 26.9% among 201 patients in the

148 At 12 months, the GOS-E distributions were as follows: death, 30.4% among 194 surgical patient

149 the ticagrelor group and the prasugrel group were as follows: death, 4.5% and 3.7%; myocardial infarc

150 tes for mental disorders among FSWs in LMICs were as follows: depression 41.8% (95% CI 35.8%-48.0%),

151 Pooled prevalence estimates of GI symptoms were as follows: diarrhea 7.7% (95% confidence interval

152 BD Max optimum assay conditions were as follows: DNA extraction at 75 degrees C for 20 m

153 Detector conditions were as follows: E1, +100 mV; E2, +550 mV; E3, -100 mV.

154 ry effectiveness of Abeta(17-36) aggregation is as follows: EGCG > resveratrol > curcumin > vanillin,

155 of the BC-GN assay with the reference method was as follows; Escherichia coli, 100%; Klebsiella pneum

156 BD Max xEBP assay for all specimens combined were as follows: ETEC, 97.6% (87.4 to 99.6), 99.8% (99.5

157 optimum operating conditions for extraction were as follows: ethanol concentration, 50%; extraction

158 Risk factors for a detectable VL were as follows: exposure to nonstandard nonnucleoside r

159 The optimised MAE conditions were as follows: extraction temperature 185 degrees C, m

160 The optimal conditions for extraction were as follows: extraction temperature 20 degrees C, ti

161 ates (95% confidence intervals) of the ARIAS were as follows: EyeArt 94.7% (94.2%-95.2%) for any reti

162 Baseline fibrosis by LB was as follows: F0, n = 71; F1, n = 242; F2, n = 236; F3

163 ual savings from measures to eliminate waste were as follows: failure of care delivery, $44.4 billion

164 The criteria were as follows: families with 2 or more cases of gastri

165 The major findings in this study are as follows: first, acute ischemic stroke hospitaliza

166 The numbers of major bleeding events were as follows: five of 152 patients in the observation

167 Median scores on admission were as follows: FM-UL = 26 (IQR 16-37), ARAT=18 (IQR 7-

168 e median scores 6 months after the programme were as follows: FM-UL=37 (IQR 24-48), ARAT=27 (IQR 12-4

169 G patients with the odds in control patients were as follows: for AD: adjusted OR, 0.84; 95% confiden

170 s of secondary end points, the hazard ratios were as follows: for death from cancer (341 deaths), 0.8

171 ge) predicted prevalence of the risk factors were as follows: for hypertension, 49% (45%-58%) among w

172 d median time to occurrence of complications were as follows: for lid margin ulceration and corneal e

173 rd ratios for the three pairwise comparisons were as follows: for low versus high pressure, 0.92 (95%

174 key secondary end points, the hazard ratios were as follows: for the expanded composite end point of

175 Toxicity to D. magna was as follows: fullerene soot > multiwall carbon nanotu

176 for plus disease from multivariate analysis were as follows: GA (OR = 3.2 for <=24 vs. >=28 weeks, P

177 k of mortality; hazard ratios (HR) (95% CIs) were as follows: general model, 0.58 (.25-1.31); model w

178 d Treatment of Cancer quality of life scores were as follows: global, 79/84 (lower worse); swallowing

179 The severity of intra-abdominal hypertension was as follows: grade I, 47.5%; grade II, 36.6%; grade I

180 56 [27-87] years; 84 female), the RLI grades were as follows: grade 0 (105 patients), grade 1 (47 pat

181 OG gastrointestinal toxic effect proportions were as follows: grade 2 or more severe toxic events in

182 cute RTOG genitourinary toxicity proportions were as follows: grade 2 or worse toxicity in 118 (27%)

183 Median metal concentrations were as follows: hair Mn, 0.08 mug/g; hair Cu, 9.6 mug/g

184 Some advantages of this method are as follows: having simple operation, easily accessib

185 tiphase, and all examinations, respectively, were as follows: head, 2 mSv (IQR, 1-3 mSv), 4 mSv (IQR,

186 tiphase, and all examinations, respectively, were as follows: head, 880 mGy .cm (IQR, 640-1120 mGy .c

187 Absolute 10-year risks of outcomes were as follows: HF: 3.18% (95% confidence interval [CI]

188 hierarchical classification of the database is as follows: homologous sets of sequences are grouped

189 These are as follows: how bacteria sense they are on a surface

190 The question we sought to address is as follows: How does the knot, which constricts the b

191 Associations with post-HSCT overall survival were as follows: HR 1.24, 95% CI 1.02-1.51; p=0.034 in t

192 e dimensions of climate change vulnerability are as follows: (i) exposure to climate change, (ii) sen

193 Accordingly, our contributions are as follows: (i) from a network perspective, we bench

194 The major steps in this protocol are as follows: (i) optimization of conditions for selec

195 The main limitations of the study are as follows: (i) the uncertainty surrounding estimate

196 rspective, notable advantages of this method are as follows: (i) water as the solvent, (ii) air as th

197 The inclusion criteria were as follows: (i) systematic recording of diet during

198 otocol optimization is identified, the steps are as follows: identification of the imaging situation;

199 e recommendations for neonatal resuscitation are as follows: In term and late-preterm newborns (>=35

200 Inclusion criteria are as follows: in-hospital cardiac arrest, age 18 years

201 -e4/e4 individuals, 5-y cumulative incidence was as follows: in the 60-64-y age stratum, it ranged fr

202 that factors associated with lower survival were as follows: increased age, a low percentage of lymp

203 , beta-amyloid (Abeta1-40/42) peptide levels were as follows: increased in the short term by insulin

204 Injured arterial vessels were as follows: inferior gluteal artery (2), superficia

205 Ts for HD and SD recipients during 2011-2012 were as follows: influenza A(H1N1), 78 (95% confidence i

206 Inclusion criteria were as follows: injured patients, age 15 years or more

207 The mean (SD) findings were as follows: intraoperative temperature, 35.9 degree

208 Mean maximum improvement was as follows: IPSS, 16 points +/- 7; quality-of-life s

209 Multivariable odds ratio estimates were as follows: ischemic heart disease 3.30 (95% confid

210 mparing dabigatran with warfarin (reference) were as follows: ischemic stroke, 0.80 (0.67-0.96); intr

211 persons with and without HIV, respectively, were as follows: Kaposi sarcoma, 4.4% and 0.01%; non-Hod

212 Prevalence of specific disorders was as follows: lifetime and current major depressive ep

213 or pyocyanin in the simulant at 37 degrees C were as follows: linear over the physiologically relevan

214 or uric acid in the simulant at 37 degrees C were as follows: linear over the physiologically relevan

215 rding to the Commission Decision 2002/657/EC are as follows: linearity (r0.99), recovery (75-108%), r

216 Fibrosis by FIB-4 was as follows: </=1, n = 148; >1 to <3.25, n = 597; >/=

217 ated absolute risks from modern radiotherapy were as follows: lung cancer, approximately 4% for long-

218 Their intensity order was as follows: (M + Cs)(+) > (M + Rb)(+) > (M + K)(+) >

219 es for those with vs without ENT examination are as follows: maximal BSA detachment (20% [0%-95%] vs

220 lume loss (mm(3)) in the steatite antagonist was as follows (mean +/- SD): PolZ = 0.022 +/- 0.007, Po

221 The PPAs for resistance markers were as follows: mecA, 97.2%; mecC, 100%; vanA, 96.8%; a

222 onization greater than 10(3) cfu/ml at Day 2 was as follows (median [interquartile range]): cylindric

223 he construction biosensor of proposed method is as follows: Metastable hairpin probe H(1) was modifie

224 1 are incorrect; the correct citations are as follows: MHC class I free heavy chain(22); HLA-B5

225 Main patterns identified were as follows: midwall in 33.3% of the hearts, transmu

226 Distribution of DR severity was as follows: mild NPDR in 11.2%, moderate NPDR in 23.

227 s metronidazole and meropenem, respectively, were as follows: mMITT population, 81.6% and 85.1% (betw

228 e factors found to be associated with myopia were as follows: more recent date of birth, female gende

229 The enzymes are as follows: MPE, a DNA endonuclease; Lhr-Core, a 3'-

230 The imputation methods we evaluated were as follows: multivariate mixed model, hidden Markov

231 Frequency of causal genes was as follows: MYBPC3 n = 123 (43.2%), MYH7 n = 69 (24.

232 D < 1 year after initiation of BEP treatment were as follows: myocardial infarction (HR, 6.3; 95% CI,

233 o the results, optimum extraction conditions were as follows: NaOH concentration of 0.76 mol/l, alkal

234 The main outcomes were as follows: need for additional intervention follow

235 ion symptoms group as a reference group, HRs were as follows: new-onset depression symptoms, 1.50 (95

236 r postrelapse survival probabilities by race were as follows: NHW, 90%; NHB, 66%; and Hispanic, 80% (

237 Distribution of DR severity was as follows: no DR, 8.8% eyes; mild nonproliferative

238 stment, significant risk factors for default were as follows: no community referral for admission, mo

239 idence intervals (CI) per 1,000 person-years were as follows: non-biologic, 14.2 (11.5-17.4); etanerc

240 ine at week 24 for omalizumab versus placebo were as follows: NPS, -1.08 versus 0.06 (P < .0001) and

241 Prerequisites are as follows: obtaining informed consent; evidencing o

242 Risk factors for both HFpEF and HFrEF were as follows: older age, white race, diabetes mellitu

243 lies with detection of the single-gene cause was as follows: onset in the first 3 months of life (69.

244 ence and severity of the anatomical patterns was as follows: open only above the navel in 48 patients

245 isons between HP groups, HP2-2 as reference, were as follows: OR HP1-1 0.73, 95% CI 0.34 to 1.56 (p v

246 The cost of our 2.5-year screening programme was as follows: per patient with any-DR, euro482.85 +/-

247 strength of evidence for each type of study was as follows: perceptions (MERSQI: 7.5-10); best pract

248 ear treatment-specific AMD progression rates were as follows: placebo, 43.3%; zinc, 25.2% (P = 0.020)

249 The corresponding FibTEM-MCF values were as follows: pre-dose, 5.3 mm (1.9); post-dose, 13 m

250 he ranking of natural variability of drivers is as follows: precipitation>grazing>temperature>biodive

251 Outcomes were as follows: prevalence of CPR-type diplopia in pati

252 the association with (pooled) SiN perception was as follows: processing speed ( r = .39), inhibitory

253 The model parameters were as follows: R(2)CV=0.802, RPD=2.3 for the total phe

254 The inclusion criteria were as follows: randomized control trials, case-control

255 ORR(week24) was as follows: RCC, 63% (19/30; 95% CI, 43.9% to 80.1%)

256 Prevalent types of MF were as follows: replacement in 53.3%, interstitial-peri

257 e measures for breast MRI versus mammography were as follows, respectively: cancer detection rates, 1

258 The prevalence of second canals was as follows: right central incisor - 33.5%, left cent

259 Extracted data were as follows: RNA or DNA genome, enveloped or not, pr

260 st acquisition of the most common infections were as follows: S. aureus, 11%, 2.5 years; P. aeruginos

261 The risk of LI at day 1000 was as follows: score 0, 12.6%; score 2-5, 25.5%; score

262 Median (interquartile range) follow up was as follows: SCS group: 7.1 (4.1-11.8) years; control

263 en benign and malignant axillary lymph nodes was as follows: sensitivity - 60%; specificity - 91.3%;

264 el or per-lesion level, the pooled estimates were as follows: sensitivity 0.84 (95%CI, 0.80-0.87), sp

265 standard" and following discrepancy analysis were as follows: sensitivity, 82% and 87%, respectively;

266 ies admitted but without the characteristic) are as follows: septic shock, 7.27 (7.19-7.35); metastat

267 The scanning protocol was as follows: slice thickness 0.625 mm, pitch 1.3, gan

268 ratio and 95% CI for death by fibrosis stage were as follows: stage 1, 1.3 (0.4-4.11), P = 0.677; sta

269 nfidence interval (95% CI) by fibrosis stage were as follows: stage 1, 2.3 (0.27-20.3), P = 0.443; st

270 The AJCC prognostic and anatomical groupings were as follows: stage I, 1030 (32.0%); stage IIA, 1095

271 The three intervention arms were as follows: standard cash (SC), a cash transfer of

272 The method performance characteristics were as follows: suitable linearity ranges for all 23 my

273 e Events scores (0 to 4 scale, higher worse) were as follows: swallowing, 0.5/0.7, and dry mouth, 0.4

274 The analysed parameters were as follows: symptoms upon admission and after treat

275 p at 20 weeks, least square mean differences were as follows: systolic ejection time 25 ms (95% CI 18

276 TNM classifications were as follows: T1N0M0, 74 patients (29.1%); T2aN0M0, 9

277 The variables analyzed were as follows: taxonomic classification; genome length

278 e EROD-active congeners in all three species was as follows: TCDD>dibenz[ah]anthracene>benzo[k]fluora

279 Stages of the care cascade were as follows: tested, diagnosed, lifestyle advice and

280 These elements are as follows: the "treatment stage migration" strategy

281 The optimal experimental conditions were as follows: the amount of MOF-545, 10mg; pH of samp

282 Independent risk factors for SRs during SCIT were as follows: the use of natural extracts (odds ratio

283 The correct statement is as follows: "...the Collaborative Research Center TRR

284 pithelial indices associated with worse BCVA were as follows: thinner 3 mm central (P = .04), thicker

285 The correct acknowledgement is as follows: "This Review was planned as part of the a

286 ed of the 5 individual risk factors assessed were as follows: tobacco 92.9%; blood pressure 51.2%; bo

287 Mean lipid values were as follows: total cholesterol: 177.3 +/- 33.1 mg/dl

288 endently associated with inferior PFS and OS were as follows: TP53 aberration, prior treatment, beta-

289 The HT regimens were as follows: trabectedin in HG-MLPS; gemcitabine plu

290 Epicardial-endocardial distributions were as follows: trabecular 26.1% and subendocardial 20.

291 them, the distribution of UGI cancer by age was as follows: under age 26 years, 9 patients (0.9 %);

292 Main recommendations are as follows: US is the method of choice when assessin

293 The surgery-to-BMS-PCI hazard ratios (HR) were as follows: versus SA-CABG, HR: 0.87; and versus MA

294 ion metrics between prone and supine imaging were as follows: volume, 23.8% (range, -30% to 103.95%);

295 for reduction of all three Alternaria toxins were as follows: w=24g/100g, q=25kg/h, v=390rpm, with a

296 The philosophical premise is as follows: when clinical data are used to provide ca

297 ly senior patients, and late senior patients were as follows: witnessed arrest in 53.8%, 51.1%, and 5

298 Participant characteristics were as follows: women: 65%; African American: 88%; hype

299 The optimum conditions of MAE were as follows: X1=2.15min; X2=517W; X3=2.26 and X4=2g/

300 retinal sensitivity in the various subzones was as follows: Zone 1 = 13.7 +/- 4.7, Zone 2 = 20.3 +/-